Clinical Guest Contributors

  1. The New Clinical Trial Regulatory Landscape Balances Speed, Quality, and Compliance — Are You Ready? 10/19/2026

    Part one of this two-part series explores how clinical trial regulation aims to balance speed, quality, compliance, and digital innovation.

  2. Get Ready For Regulators With This Speed-Quality-Compliance Framework 10/19/2026

    Part two of a two-part series, experts Sapna Rani and Shaun Hastings offer a five-part framework to balance speed, quality, and compliance amid evolving clinical trial regulations.

  3. The U.S. Clinical Trial Recruiting Pipeline – September 2026 10/16/2026

    This WhichTrial report breaks down which drug trials are growing the most and the least, drugs that are no longer being studied, and new drugs to the clinic from August to September.

  4. Can Psychedelic‑Assisted Treatment Redefine Emotional Care In Oncology? 10/16/2026

    Psychedelic-assisted treatment may offer faster, lasting relief for cancer patients facing adjustment disorder, depression, and anxiety.

  5. Unlocking AI Value For Clinical Research Associates 10/15/2026

    Clinical research associates (CRAs) have largely been late to adopt AI. CRAs who adopt it can streamline repetitive work while also freeing capacity for high-judgment work.

  6. Your EDC Query Count Is Trying To Tell You Something 10/14/2026

    A rising EDC query count may reveal more than dirty data. Learn how query patterns can expose upstream problems in trial workflows, training, and CRF design.

  7. Can A Universal Health Screening Help Stop Clinical Trial Dropouts? 10/13/2026

    Could comprehensive health scans give trial participants meaningful value — and help sponsors reduce costly dropouts?

  8. Can Your Team Coordinate The CRO Model You've Chosen? 10/12/2026

    Choosing the right CRO model matters less than a sponsor’s ability to coordinate it. Here’s how to match outsourcing strategy to internal capacity.

  9. To Pick The Right Medical LLM, First Assess Your Readiness 10/9/2026

    Learn how to evaluate medical LLMs for clinical trials by weighing readiness, risk, validation, integration, hidden costs, and supplier controls.

  10. Your Company Needs Compliance Expertise — But When And From Whom? 10/8/2026

    When should a biotech formalize compliance? Learn how risk, funding, clinical activity, and commercialization shape the right expertise and structure.